DK2091537T3 - Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati - Google Patents

Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati

Info

Publication number
DK2091537T3
DK2091537T3 DK07846885.7T DK07846885T DK2091537T3 DK 2091537 T3 DK2091537 T3 DK 2091537T3 DK 07846885 T DK07846885 T DK 07846885T DK 2091537 T3 DK2091537 T3 DK 2091537T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical compositions
capillary arteriopathy
arteriopathy
capillary
Prior art date
Application number
DK07846885.7T
Other languages
English (en)
Inventor
Rudolf Reiter
Johannes Tack
Reinhard Horowski
Original Assignee
Sinoxa Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinoxa Pharma Gmbh filed Critical Sinoxa Pharma Gmbh
Application granted granted Critical
Publication of DK2091537T3 publication Critical patent/DK2091537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
DK07846885.7T 2006-11-23 2007-11-23 Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati DK2091537T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06024308 2006-11-23
EP06025263 2006-12-06
PCT/EP2007/010360 WO2008061805A1 (de) 2006-11-23 2007-11-23 Pharmazeutische zusammensetzungen zur behandlung von kapillarer arteriopathie

Publications (1)

Publication Number Publication Date
DK2091537T3 true DK2091537T3 (da) 2013-08-26

Family

ID=38982525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07846885.7T DK2091537T3 (da) 2006-11-23 2007-11-23 Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati

Country Status (14)

Country Link
US (2) US20090325997A1 (da)
EP (1) EP2091537B1 (da)
JP (1) JP5407865B2 (da)
AU (1) AU2007324706B2 (da)
CA (1) CA2670846C (da)
CY (1) CY1114364T1 (da)
DK (1) DK2091537T3 (da)
ES (1) ES2425581T3 (da)
HR (1) HRP20130791T1 (da)
PL (1) PL2091537T3 (da)
PT (1) PT2091537E (da)
RU (1) RU2463048C2 (da)
SI (1) SI2091537T1 (da)
WO (1) WO2008061805A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010051391A1 (de) 2010-11-11 2012-10-11 Sinoxa Pharma Ug Multivalente Arzneistoffe mit kombinierter antioxidativer Wirkung und antagonistischen Effekten an 5-HT2-Rezeptor-Subtypen zur Behandlung von fibrotischem Organumbau.
EP2550959A1 (de) * 2011-07-27 2013-01-30 Sinoxa Pharma Lisurid, Tergurid und Derivate davon zur Verwendung in der Prophylaxe und/oder Therapie fibrotischer Veränderungen
CN103476402A (zh) * 2010-11-11 2013-12-25 西诺克萨医药有限公司 用于预防和/或治疗纤维化病变的麦角乙脲、特麦角脲及其衍生物
RU2516921C1 (ru) * 2013-04-08 2014-05-20 Общество с ограниченной ответственностью "Научно-производственная компания ВИТАФОРМ" Композиция для костной пластики (варианты)
CA2974117A1 (en) 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc. Ergoline compounds and uses thereof
EP3528812B1 (en) * 2016-10-20 2020-12-30 Pfizer Inc Palbociclib for treating pah
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
WO2023107931A1 (en) * 2021-12-06 2023-06-15 Terran Biosciences, Inc. Salt and solid forms of indole analogs and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
EP1438019A1 (en) * 2001-10-24 2004-07-21 PARI GmbH Spezialisten für effektive Inhalation Kit for the preparation of a pharmaceutical composition
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN103476402A (zh) * 2010-11-11 2013-12-25 西诺克萨医药有限公司 用于预防和/或治疗纤维化病变的麦角乙脲、特麦角脲及其衍生物

Also Published As

Publication number Publication date
PT2091537E (pt) 2013-08-29
US20140045879A1 (en) 2014-02-13
AU2007324706A1 (en) 2008-05-29
RU2463048C2 (ru) 2012-10-10
CA2670846A1 (en) 2008-05-29
AU2007324706B2 (en) 2013-09-05
US20090325997A1 (en) 2009-12-31
AU2007324706A2 (en) 2009-06-25
JP2010510273A (ja) 2010-04-02
WO2008061805A1 (de) 2008-05-29
EP2091537B1 (de) 2013-05-22
CY1114364T1 (el) 2016-08-31
PL2091537T3 (pl) 2013-10-31
SI2091537T1 (sl) 2013-10-30
JP5407865B2 (ja) 2014-02-05
EP2091537A1 (de) 2009-08-26
RU2009123401A (ru) 2010-12-27
US9695173B2 (en) 2017-07-04
CA2670846C (en) 2014-12-23
HRP20130791T1 (en) 2013-09-30
ES2425581T3 (es) 2013-10-16

Similar Documents

Publication Publication Date Title
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK1928405T3 (da) Farmaceutiske sammensætninger til behandling af indre øreforstyrrelser
DK3354276T3 (da) Sammensætninger til behandlingen af gastrointestinal inflammation
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
BRPI0715712A2 (pt) Composição farmacêutica
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
BRPI0719393A2 (pt) Composição farmacêutica
DK1868579T3 (da) Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2041139T3 (da) Farmaceutiske forbindelser
DK2220116T3 (da) Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2034830T3 (da) Anti-vla-1-antistof til behandling af slagtilfælde
BRPI0720234A2 (pt) Composição farmacêutica
DK1942967T3 (da) Fremgangsmåde til dosering af medikamenter
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK3300743T3 (da) Fremgangsmåder til indgivelse af vaccine
DK2091537T3 (da) Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati
DK2010184T3 (da) Implatanter til behandlingen af dopamin associerede tilstande
DK2216021T3 (da) Farmaceutisk sammensætning til behandling af overaktiv blære